scholarly article | Q13442814 |
P2093 | author name string | Maxine L Linial | |
Scott W Eastman | |||
Eun-Gyung Lee | |||
Rachel B Life | |||
P2860 | cites work | High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells | Q24548319 |
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 | ||
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system | Q24628961 | ||
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids | Q24646680 | ||
Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. | Q27919668 | ||
Aggresomes and autophagy generate sites for virus replication | Q28239704 | ||
Ancient co-speciation of simian foamy viruses and primates | Q28240174 | ||
The roles of Pol and Env in the assembly pathway of human foamy virus. | Q33782618 | ||
Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. | Q33815050 | ||
Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly | Q33844222 | ||
Type D retrovirus Gag polyprotein interacts with the cytosolic chaperonin TRiC. | Q33865019 | ||
Review: cellular substrates of the eukaryotic chaperonin TRiC/CCT. | Q34387488 | ||
Trafficking and signaling by fatty-acylated and prenylated proteins | Q34575170 | ||
A Tyrosine Motif in the Cytoplasmic Domain of Mason-Pfizer Monkey Virus Is Essential for the Incorporation of Glycoprotein into Virions | Q34975304 | ||
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain | Q35745733 | ||
Expression and maturation of human foamy virus Gag precursor polypeptides. | Q35877526 | ||
Membrane targeting of lipid modified signal transduction proteins. | Q35891428 | ||
Ubiquitin-dependent virus particle budding without viral protein ubiquitination | Q36289026 | ||
Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors | Q36362910 | ||
Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay | Q36654386 | ||
Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids | Q36886315 | ||
Aggresomes and pericentriolar sites of virus assembly: cellular defense or viral design? | Q36951982 | ||
Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors | Q36954062 | ||
Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression | Q37348250 | ||
Myristoylation of the RING finger Z protein is essential for arenavirus budding | Q37568060 | ||
Foamy virus capsids require the cognate envelope protein for particle export | Q39549687 | ||
A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. | Q39603094 | ||
Foamy virus particle formation | Q39642443 | ||
Foamy virus envelope glycoprotein is sufficient for particle budding and release | Q39700302 | ||
The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains | Q39877095 | ||
Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. | Q40272140 | ||
RNA and protein requirements for incorporation of the Pol protein into foamy virus particles | Q40423235 | ||
Aggresomes resemble sites specialized for virus assembly | Q40603651 | ||
M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome | Q40637604 | ||
The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell | Q40637610 | ||
Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis | Q40643255 | ||
An NH2-terminal peptide from the vaccinia virus L1R protein directs the myristylation and virion envelope localization of a heterologous fusion protein | Q41560381 | ||
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of thebel 1 gene | Q41668478 | ||
Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase | Q41714481 | ||
A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus | Q41718633 | ||
Role of the foamy virus Pol cleavage site in viral replication | Q42737934 | ||
Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. | Q43882545 | ||
Formation of aggresome-like structures in herpes simplex virus type 2-infected cells and a potential role in virus assembly. | Q45046123 | ||
Myristic acid analogs are inhibitors of Junin virus replication | Q45745440 | ||
Foamy virus vectors | Q70792195 | ||
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infectivity | Q1662346 |
P304 | page(s) | 6109-6119 | |
P577 | publication date | 2008-04-23 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly | |
P478 | volume | 82 |
Q39369916 | A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors |
Q27678148 | A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid |
Q28685457 | An N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivity |
Q39703179 | Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles |
Q41812437 | Basic residues in the foamy virus Gag protein |
Q45354422 | Characterization and manipulation of foamy virus membrane interactions |
Q28727984 | Drosophila errantiviruses |
Q26860084 | Foamy virus assembly with emphasis on pol encapsidation |
Q27015997 | Foamy virus budding and release |
Q36333631 | In Vitro Evolution of Bovine Foamy Virus Variants with Enhanced Cell-Free Virus Titers and Transmission |
Q37743255 | Molecular biology of foamy viruses |
Q37195958 | Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding |
Q33743796 | N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm |
Q39429166 | N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles |
Q28673358 | Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission |
Q37071705 | Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7 |
Q42243643 | Residues R(199)H(200) of prototype foamy virus transactivator Bel1 contribute to its binding with LTR and IP promoters but not its nuclear localization |
Q35038590 | Tetherin inhibits prototypic foamy virus release |
Q39948850 | The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions |
Q38093352 | The foamy virus Gag proteins: what makes them different? |
Search more.